Loading clinical trials...
Loading clinical trials...
Evaluation of Dotarem-enhanced Magnetic Resonance Angiography (MRA) Compared to Time-Of-Flight (TOF) MRA in the Diagnosis of Renal Arterial Disease
Conditions
Interventions
Dotarem
Time of Flight
Locations
1
United States
Guerbet LLC
Bloomington, Indiana, United States
Start Date
September 1, 2009
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
May 26, 2016
NCT04634916
NCT06933472
NCT07146854
NCT04163614
NCT04580420
NCT07224763
Lead Sponsor
Guerbet
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions